Fed Day
The Fed is meeting to discuss the next steps in monetary policy. The consensus is that they will raise the Target Fed Funds Rate by 0.25%. This will bring the…
Exxon Update: XOM
On 8-May-2023, we discussed a buy-write, aka covered call strategy applied to Exxon Mobile stock. This article is for paid members - please login or subscribe for access.
The Week Ahead | 07/24/2023
Welcome back to our weekly roundup, where we shed light on the ever-evolving economic landscape. As we embark on another bustling week of economic news, I find myself particularly focused…
Discover Financial Service: DFS
Discover Financial Services (DFS) reported Q2 2023 earnings last week, and traders were unimpressed. Traders took the stock down $19.40 a share or 15.9%. Our question is, "Were the results…
Royal Caribbean Cruises Ltd, Cruisin’ for a Bruisin’?: RCL
Few industries were hit harder than the cruise industry during the C-19 lockdown. The reason for this is clear. This article is for paid members - please login or subscribe…
STMicroelectronics NV: STM
Finding an un devalued stock in the tech space is becoming more challenging. Investors have bid up the price of software and device companies assuming they will perform to perfection.…
Microstrategy 2nd Update: MSTR
One of the biggest, if not the biggest winner we have ever discussed here at theOptionsEdge.Com, is Microstrategy, the business intelligence software company and largest publicly traded bitcoin holder. This…
The Week Ahead | 07/17/2023
Welcome to another exciting week ahead! As we navigate through the mid-July, we continue to embrace the dynamic ebb and flow of the markets, keeping a keen eye on global…
Is Estee Lauder Companies Looking Pretty?: EL
Estee Lauder is one of the big success stories in the Beauty Industry. It has a highly recognized brand name and has historically captured a price premium for the high-quality…
T-Mobile: TMUS
T-Mobile stock was the big winner in the wireless wars between ATT, Verison & T-Mobile. Will it continue to be a winner, or is growth through acquisition and market-share accretion…
Abbvie Inc.: ABBV
Companies in the biopharmaceutical are challenging to get your arms around. The development of pharmaceutical treatments is highly technical and requires scientific insight. Further, developing these therapies is expensive and…
Charles Schwab & Co: SCHW
The regional banks had a meltdown due to poor asset liability management. Some of their troubles were caused by the government that sold massive amounts of debt to pay for…